231 related articles for article (PubMed ID: 22733133)
1. The p53 isoform, Δ133p53α, stimulates angiogenesis and tumour progression.
Bernard H; Garmy-Susini B; Ainaoui N; Van Den Berghe L; Peurichard A; Javerzat S; Bikfalvi A; Lane DP; Bourdon JC; Prats AC
Oncogene; 2013 Apr; 32(17):2150-60. PubMed ID: 22733133
[TBL] [Abstract][Full Text] [Related]
2. Expression of p53 isoforms in renal cell carcinoma.
Song W; Huo SW; Lü JJ; Liu Z; Fang XL; Jin XB; Yuan MZ
Chin Med J (Engl); 2009 Apr; 122(8):921-6. PubMed ID: 19493415
[TBL] [Abstract][Full Text] [Related]
3. p53 isoforms Delta133p53 and p53beta are endogenous regulators of replicative cellular senescence.
Fujita K; Mondal AM; Horikawa I; Nguyen GH; Kumamoto K; Sohn JJ; Bowman ED; Mathe EA; Schetter AJ; Pine SR; Ji H; Vojtesek B; Bourdon JC; Lane DP; Harris CC
Nat Cell Biol; 2009 Sep; 11(9):1135-42. PubMed ID: 19701195
[TBL] [Abstract][Full Text] [Related]
4. The Δ133p53 Isoforms, Tuners of the p53 Pathway.
Joruiz SM; Beck JA; Horikawa I; Harris CC
Cancers (Basel); 2020 Nov; 12(11):. PubMed ID: 33218139
[TBL] [Abstract][Full Text] [Related]
5. Expression of p53 N-terminal isoforms in B-cell precursor acute lymphoblastic leukemia and its correlation with clinicopathological profiles.
Oh L; Hainaut P; Blanchet S; Ariffin H
BMC Cancer; 2020 Feb; 20(1):110. PubMed ID: 32041553
[TBL] [Abstract][Full Text] [Related]
6. Elevation of the TP53 isoform Δ133p53β in glioblastomas: an alternative to mutant p53 in promoting tumor development.
Kazantseva M; Eiholzer RA; Mehta S; Taha A; Bowie S; Roth I; Zhou J; Joruiz SM; Royds JA; Hung NA; Slatter TL; Braithwaite AW
J Pathol; 2018 Sep; 246(1):77-88. PubMed ID: 29888503
[TBL] [Abstract][Full Text] [Related]
7. Differential effects of diverse p53 isoforms on TAp73 transcriptional activity and apoptosis.
Zorić A; Horvat A; Slade N
Carcinogenesis; 2013 Mar; 34(3):522-9. PubMed ID: 23188674
[TBL] [Abstract][Full Text] [Related]
8. Dipalmitoylphosphatidic acid inhibits breast cancer growth by suppressing angiogenesis via inhibition of the CUX1/FGF1/HGF signalling pathway.
Chen J; Zhou Z; Yao Y; Dai J; Zhou D; Wang L; Zhang QQ
J Cell Mol Med; 2018 Oct; 22(10):4760-4770. PubMed ID: 30010249
[TBL] [Abstract][Full Text] [Related]
9. p53 directly transactivates Δ133p53α, regulating cell fate outcome in response to DNA damage.
Aoubala M; Murray-Zmijewski F; Khoury MP; Fernandes K; Perrier S; Bernard H; Prats AC; Lane DP; Bourdon JC
Cell Death Differ; 2011 Feb; 18(2):248-58. PubMed ID: 20689555
[TBL] [Abstract][Full Text] [Related]
10. The RNA helicase p68 modulates expression and function of the Δ133 isoform(s) of p53, and is inversely associated with Δ133p53 expression in breast cancer.
Moore HC; Jordan LB; Bray SE; Baker L; Quinlan PR; Purdie CA; Thompson AM; Bourdon JC; Fuller-Pace FV
Oncogene; 2010 Dec; 29(49):6475-84. PubMed ID: 20818423
[TBL] [Abstract][Full Text] [Related]
11. Loss of endothelial programmed cell death 10 activates glioblastoma cells and promotes tumor growth.
Zhu Y; Zhao K; Prinz A; Keyvani K; Lambertz N; Kreitschmann-Andermahr I; Lei T; Sure U
Neuro Oncol; 2016 Apr; 18(4):538-48. PubMed ID: 26254477
[TBL] [Abstract][Full Text] [Related]
12. p73 coordinates with Δ133p53 to promote DNA double-strand break repair.
Gong H; Zhang Y; Jiang K; Ye S; Chen S; Zhang Q; Peng J; Chen J
Cell Death Differ; 2018 Jun; 25(6):1063-1079. PubMed ID: 29511339
[TBL] [Abstract][Full Text] [Related]
13. Effects of tumor suppressor gene (p53) on brain tumor angiogenesis and expression of angiogenic modulators.
Tse V; Yung Y; Santarelli JG; Juan D; Hsiao M; Haas M; Harsh G; Silverberg G
Anticancer Res; 2004; 24(1):1-10. PubMed ID: 15015569
[TBL] [Abstract][Full Text] [Related]
14. Balance of pro- versus anti-angiogenic splice isoforms of vascular endothelial growth factor as a regulator of neuroblastoma growth.
Peiris-Pagès M; Harper SJ; Bates DO; Ramani P
J Pathol; 2010 Oct; 222(2):138-47. PubMed ID: 20662003
[TBL] [Abstract][Full Text] [Related]
15. Plumbagin inhibits tumour angiogenesis and tumour growth through the Ras signalling pathway following activation of the VEGF receptor-2.
Lai L; Liu J; Zhai D; Lin Q; He L; Dong Y; Zhang J; Lu B; Chen Y; Yi Z; Liu M
Br J Pharmacol; 2012 Feb; 165(4b):1084-96. PubMed ID: 21658027
[TBL] [Abstract][Full Text] [Related]
16. Versican V2 isoform enhances angiogenesis by regulating endothelial cell activities and fibronectin expression.
Yang W; Yee AJ
FEBS Lett; 2013 Jan; 587(2):185-92. PubMed ID: 23201264
[TBL] [Abstract][Full Text] [Related]
17. Δ160p53 is a novel N-terminal p53 isoform encoded by Δ133p53 transcript.
Marcel V; Perrier S; Aoubala M; Ageorges S; Groves MJ; Diot A; Fernandes K; Tauro S; Bourdon JC
FEBS Lett; 2010 Nov; 584(21):4463-8. PubMed ID: 20937277
[TBL] [Abstract][Full Text] [Related]
18. Δ122p53, a mouse model of Δ133p53α, enhances the tumor-suppressor activities of an attenuated p53 mutant.
Slatter TL; Hung N; Bowie S; Campbell H; Rubio C; Speidel D; Wilson M; Baird M; Royds JA; Braithwaite AW
Cell Death Dis; 2015 Jun; 6(6):e1783. PubMed ID: 26068791
[TBL] [Abstract][Full Text] [Related]
19. p53 isoforms regulate aging- and tumor-associated replicative senescence in T lymphocytes.
Mondal AM; Horikawa I; Pine SR; Fujita K; Morgan KM; Vera E; Mazur SJ; Appella E; Vojtesek B; Blasco MA; Lane DP; Harris CC
J Clin Invest; 2013 Dec; 123(12):5247-57. PubMed ID: 24231352
[TBL] [Abstract][Full Text] [Related]
20. Cytoplasmic p53β Isoforms Are Associated with Worse Disease-Free Survival in Breast Cancer.
Steffens Reinhardt L; Groen K; Morten BC; Bourdon JC; Avery-Kiejda KA
Int J Mol Sci; 2022 Jun; 23(12):. PubMed ID: 35743117
[No Abstract] [Full Text] [Related]
[Next] [New Search]
